<DOC>
	<DOCNO>NCT01294774</DOCNO>
	<brief_summary>This study ass safety efficacy KRP203 clinically active subacute cutaneous lupus erythematosus patient , demonstrate inadequate response standard treatment , antimalarial .</brief_summary>
	<brief_title>Safety Efficacy KRP203 Subacute Cutaneous Lupus Erythematosus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Lupus Erythematosus , Cutaneous</mesh_term>
	<criteria>Male female patients,18 65 year age inclusive , define SCLE base typical clinical picture characteristic histopathological feature describe Sontheimer et al . least three month study entry ( screen ) 1 . Patients preexist nephritis , central nervous pulmonary involvement major internal organ damage , either relate unrelated lupus , deem Investigator clinically significant . Patients sign symptom autoimmune disease systemic lupus erythematosus Sjogren ` syndrome allow enter study Investigator ` discretion . 2 . Patients treat : immunoglobulin and/or monoclonal antibody within 6 month prior randomization . rituximab , cyclophosphamide , immunosuppressive treatment effect potentially last 6 month , within 12 month prior randomization . medium high dose ( â‰¥ 1 mg prednisone equivalent per body weight kg ) corticosteroid therapy last 8 week prior randomization . antimalarial agent ( hydroxychloroquine , chloroquine quinacrine ) last 6 week prior randomization . biologic therapy , etanercept , within last 4 week prior randomization . immunosuppressive immunomodulatory therapy methotrexate , azathioprine , cyclosporin A mycophenolate , thalidomide , retinoids dapsone last 4 week prior randomization . total lymphoid irradiation bone marrow transplantation . 3 . Pregnant , plan get pregnant , and/or lactating female male plan father child within time period study subsequent exclusionary period . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Lupus erythematosus</keyword>
	<keyword>skin lupus</keyword>
</DOC>